BR112012030653A2 - composição tópica em aerosol, estável ao armazenamento e substancialmente anidra, e, recipiente pressurizado - Google Patents

composição tópica em aerosol, estável ao armazenamento e substancialmente anidra, e, recipiente pressurizado

Info

Publication number
BR112012030653A2
BR112012030653A2 BR112012030653A BR112012030653A BR112012030653A2 BR 112012030653 A2 BR112012030653 A2 BR 112012030653A2 BR 112012030653 A BR112012030653 A BR 112012030653A BR 112012030653 A BR112012030653 A BR 112012030653A BR 112012030653 A2 BR112012030653 A2 BR 112012030653A2
Authority
BR
Brazil
Prior art keywords
aerosol composition
pressurized container
substantially anhydrous
storage stable
topical aerosol
Prior art date
Application number
BR112012030653A
Other languages
English (en)
Other versions
BR112012030653B1 (pt
Inventor
Gritt Rasmussen
Jens Hansen
Karsten Petersson
Marianne Lind
Mette Rydahl Sonne
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44475023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012030653(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of BR112012030653A2 publication Critical patent/BR112012030653A2/pt
Publication of BR112012030653B1 publication Critical patent/BR112012030653B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/16—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant characterised by the actuating means
    • B65D83/20—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant characterised by the actuating means operated by manual action, e.g. button-type actuator or actuator caps
    • B65D83/207—Actuators comprising a manually operated valve and being attachable to the aerosol container, e.g. downstream a valve fitted to the container; Actuators associated to container valves with valve seats located outside the aerosol container
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants

Abstract

composição tópica em aerosol, estável ao armazenamento e substancialmente anidra, e, recipiente pressurizado. a presente invenção se refere a uma composição em aerosol tópica, que compreende um derivado de vitamina d biologicamente ativo e um corticosteróide, e ao seu uso no tratamento de doenças e condições dérmicas. o aerosol compreende especialmente um propelente selecionado do grupo que consiste em dimetil éter, dietil éter e metiletil éter, ou uma mistura destes, e adicionalmente um carreador lipídico farmaceuticamente aceitável, solubilizado ou suspenso no dito propelente.
BR112012030653-7A 2010-06-11 2011-06-10 Composição tópica em aerossol, e, recipiente pressurizado BR112012030653B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35389310P 2010-06-11 2010-06-11
US61/353,893 2010-06-11
PCT/DK2011/000060 WO2011154004A1 (en) 2010-06-11 2011-06-10 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid

Publications (2)

Publication Number Publication Date
BR112012030653A2 true BR112012030653A2 (pt) 2016-08-16
BR112012030653B1 BR112012030653B1 (pt) 2021-10-13

Family

ID=44475023

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012030653-7A BR112012030653B1 (pt) 2010-06-11 2011-06-10 Composição tópica em aerossol, e, recipiente pressurizado

Country Status (26)

Country Link
US (11) US9119781B2 (pt)
EP (2) EP2859886A1 (pt)
JP (3) JP5945268B2 (pt)
KR (2) KR101749514B1 (pt)
CN (1) CN102939078B (pt)
AU (1) AU2011264198B2 (pt)
BR (1) BR112012030653B1 (pt)
CA (1) CA2800181C (pt)
CY (1) CY1115991T1 (pt)
DK (1) DK2579852T3 (pt)
ES (1) ES2529506T3 (pt)
HK (1) HK1182321A1 (pt)
HR (1) HRP20150154T1 (pt)
IL (2) IL222865A (pt)
MX (1) MX2012013591A (pt)
MY (1) MY167691A (pt)
NZ (1) NZ603470A (pt)
PL (1) PL2579852T3 (pt)
PT (1) PT2579852E (pt)
RS (1) RS53809B1 (pt)
RU (1) RU2576607C2 (pt)
SG (1) SG185521A1 (pt)
SI (1) SI2579852T1 (pt)
UA (1) UA109785C2 (pt)
WO (1) WO2011154004A1 (pt)
ZA (1) ZA201208281B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
KR101749514B1 (ko) * 2010-06-11 2017-06-21 레오 파마 에이/에스 비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물
KR20150027831A (ko) * 2012-07-06 2015-03-12 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
WO2014197398A1 (en) * 2013-06-03 2014-12-11 Tolmar, Inc. Corticosteroid compositions
JP2017515851A (ja) * 2014-05-13 2017-06-15 パラゴン ノルディック エービー 植物油とトリグリセリドおよび／または鉱油とを含み噴霧特性が改善された組成物
CN105708842B (zh) * 2014-12-03 2020-06-26 四川海思科制药有限公司 一种外用药物组合物
US9265727B1 (en) 2015-01-14 2016-02-23 Delcor Asset Corporation Spray foam corticosteroid product
CN104490782B (zh) * 2015-01-20 2017-04-12 北京康蒂尼药业有限公司 一种外用温控泡沫剂及其制备方法和用途
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
CN104800187B (zh) * 2015-04-22 2017-07-14 青岛正大海尔制药有限公司 一种阿法骨化醇软胶囊及其制备方法
KR101641372B1 (ko) * 2015-05-08 2016-07-20 (주)동구바이오제약 안정성과 피부투과율이 향상된 약학 조성물
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US20180028767A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Topical spray system of halobetasol
EP3515422A1 (en) 2016-09-21 2019-07-31 Avexxin AS Pharmaceutical composition
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
KR20210100129A (ko) 2018-11-29 2021-08-13 에디컨인코포레이티드 수술실 코팅 어플리케이터 및 방법
CN110302194B (zh) * 2019-07-23 2023-01-31 广州市皮肤病防治所(广州市性病防治监测中心) 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂
GB201914498D0 (en) * 2019-10-08 2019-11-20 Leo Pharma As An anhydrous pharmaceutical composition for maintenance treatment of psoriasis
US11589867B2 (en) 2020-05-28 2023-02-28 Ethicon, Inc. Anisotropic wound closure systems
US11712229B2 (en) 2020-05-28 2023-08-01 Ethicon, Inc. Systems, devices and methods for dispensing and curing silicone based topical skin adhesives
US11718753B2 (en) 2020-05-28 2023-08-08 Ethicon, Inc. Topical skin closure compositions and systems
US11518604B2 (en) * 2020-05-28 2022-12-06 Ethicon, Inc. Systems, methods and devices for aerosol spraying of silicone based topical skin adhesives for sealing wounds
US11479669B2 (en) 2020-05-28 2022-10-25 Ethicon, Inc. Topical skin closure compositions and systems
CN111904679A (zh) * 2020-07-31 2020-11-10 李光娟 一种皮肤科脓疮护理装置
US20230414537A1 (en) * 2022-06-21 2023-12-28 Taro Pharmaceutical Industries Ltd. Topical naftifine compositions

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3722753A (en) 1966-12-01 1973-03-27 Colgate Palmolive Co Dispensing attachment for pressurized containers
US4087026A (en) 1971-09-15 1978-05-02 Petterson Tor H Barrier package
US4411883A (en) * 1973-02-05 1983-10-25 Colgate-Palmolive Company Antiperspirant
US4122978A (en) 1975-06-18 1978-10-31 The Gillette Company Pressurized package for dispensing a product in a finely dispersed spray pattern with little dilution by propellant
JP2772073B2 (ja) 1989-11-14 1998-07-02 東洋エアゾール工業株式会社 粉末エアゾール組成物
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5098694A (en) * 1990-09-25 1992-03-24 The Procter & Gamble Company Natural deodorant compositions
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
US5763426A (en) 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
DE69414710T2 (de) 1993-08-10 1999-04-08 Boots Co Ltd Spruehformulierung mit kuehleffekt
JP3881400B2 (ja) 1995-02-22 2007-02-14 久光製薬株式会社 エアゾール組成物及びエアゾール型外用製剤
US5635165A (en) * 1995-09-27 1997-06-03 Helene Curtis, Inc. Antiperspirant deodorant compositions
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JPH10182375A (ja) 1996-12-27 1998-07-07 Mirubon:Kk スプレー式酸性染毛料
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
JP2000063254A (ja) 1998-08-19 2000-02-29 Kanpehapio:Kk 皮膚保護クリーム
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
JP2000086500A (ja) 1998-09-18 2000-03-28 Toyo Aerosol Ind Co Ltd エアゾール型軟膏組成物
HU230045B1 (hu) 1999-04-23 2015-06-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
HU230005B1 (en) 2000-10-27 2015-04-28 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
JP2002138015A (ja) 2000-10-27 2002-05-14 Toyo Aerosol Ind Co Ltd スプレー組成物
JP2002241309A (ja) 2001-02-20 2002-08-28 Toyo Aerosol Ind Co Ltd 消炎剤組成物および消炎エアゾール製品
JP4450545B2 (ja) * 2001-07-05 2010-04-14 ロート製薬株式会社 エアゾール製剤
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
JP2006511545A (ja) 2002-12-17 2006-04-06 ガルデルマ・ソシエテ・アノニム カルシトリオール及びプロピオン酸クロベタゾールの組み合わせ物を含む医薬組成物
FR2852239B1 (fr) 2003-03-11 2006-08-11 Oreal Dispositif aerosol contenant une composition cosmetique comprenant un poluyrethane et un agent propulseur comprenant du dimethylether et au moins un hydrocarbure
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871700B1 (fr) 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
BRPI0511387A (pt) 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
FR2871698B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
CA2567683A1 (en) 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
US7134579B2 (en) 2004-11-15 2006-11-14 Ultramotive Corporation RTV silicone spray system
WO2006111426A1 (en) 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
CA2610662A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
ES2407407T3 (es) 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina
US7698878B2 (en) 2005-10-17 2010-04-20 Dispensing Patents International, Llc Aerosol container with integral mounting cup and anti-clog valve
AU2006326033A1 (en) 2005-12-14 2007-06-21 Zars Pharma, Inc. Spray-on formulations and methods for dermal delivery of drugs
JP4909651B2 (ja) 2006-06-12 2012-04-04 株式会社ダイゾー 噴霧用エアゾール組成物
MX2009000147A (es) * 2006-06-27 2009-06-11 Schering Plough Healthcare Formulaciones de locion en aerosol.
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AU2007355106A1 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US20100189674A1 (en) * 2007-05-11 2010-07-29 Sonneborn Inc. Petrolatum Having Silicone-Like Properties
CA2711703A1 (en) * 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
JP2012505236A (ja) * 2008-10-10 2012-03-01 シェーリング コーポレイション コルチコステロイド組成物およびそれの治療方法
ES2537151T3 (es) 2009-12-10 2015-06-02 Neubourg Skin Care Gmbh & Co. Kg Formulaciones de espuma estabilizadas con polímeros, libres de emulsionantes
KR101749514B1 (ko) * 2010-06-11 2017-06-21 레오 파마 에이/에스 비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물
KR20150027831A (ko) * 2012-07-06 2015-03-12 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물

Also Published As

Publication number Publication date
DK2579852T3 (en) 2015-02-23
SG185521A1 (en) 2012-12-28
RS53809B1 (en) 2015-06-30
CA2800181A1 (en) 2011-12-15
US10688108B2 (en) 2020-06-23
UA109785C2 (uk) 2015-10-12
CY1115991T1 (el) 2017-01-25
AU2011264198B2 (en) 2015-04-09
RU2576607C2 (ru) 2016-03-10
US20190381073A1 (en) 2019-12-19
US9119781B2 (en) 2015-09-01
HRP20150154T1 (hr) 2015-04-10
CA2800181C (en) 2016-03-15
JP5945268B2 (ja) 2016-07-05
RU2013100996A (ru) 2014-07-20
EP2579852B1 (en) 2014-12-31
US10130640B2 (en) 2018-11-20
JP2013533859A (ja) 2013-08-29
US20200009160A1 (en) 2020-01-09
CN102939078A (zh) 2013-02-20
NZ603470A (en) 2014-12-24
CN102939078B (zh) 2014-12-24
US9566286B2 (en) 2017-02-14
US10617698B2 (en) 2020-04-14
US20190388439A1 (en) 2019-12-26
US20210128588A1 (en) 2021-05-06
IL222865A0 (en) 2012-12-31
PL2579852T3 (pl) 2015-04-30
EP2579852A1 (en) 2013-04-17
BR112012030653B1 (pt) 2021-10-13
US20150313919A1 (en) 2015-11-05
US20230398131A1 (en) 2023-12-14
US20190381074A1 (en) 2019-12-19
PT2579852E (pt) 2015-02-24
US20170065618A1 (en) 2017-03-09
IL222865A (en) 2016-08-31
US10660908B2 (en) 2020-05-26
US10682364B2 (en) 2020-06-16
IL247260A0 (en) 2016-09-29
MX2012013591A (es) 2013-02-01
JP2018065850A (ja) 2018-04-26
US20190015430A1 (en) 2019-01-17
SI2579852T1 (sl) 2015-03-31
JP6503445B2 (ja) 2019-04-17
ZA201208281B (en) 2014-01-29
AU2011264198A1 (en) 2012-11-29
WO2011154004A1 (en) 2011-12-15
EP2859886A1 (en) 2015-04-15
JP2016188223A (ja) 2016-11-04
US10716799B2 (en) 2020-07-21
MY167691A (en) 2018-09-21
KR101749514B1 (ko) 2017-06-21
KR20130109096A (ko) 2013-10-07
US20130123720A1 (en) 2013-05-16
US20150335575A1 (en) 2015-11-26
IL247260B (en) 2020-07-30
HK1182321A1 (en) 2013-11-29
KR20160054614A (ko) 2016-05-16
JP6258402B2 (ja) 2018-01-10
KR101619077B1 (ko) 2016-05-10
ES2529506T3 (es) 2015-02-20

Similar Documents

Publication Publication Date Title
BR112012030653A2 (pt) composição tópica em aerosol, estável ao armazenamento e substancialmente anidra, e, recipiente pressurizado
PH12015500686A1 (en) Nicotine composition
BR112012030818A2 (pt) "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv"
BR112013003045A2 (pt) composto e composição farmacêutica e respectivos usos, recipiente estéril e método para preparar composição farmacêutica para administração
CU20130069A7 (es) Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis
CA2818925A1 (en) Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
GEP20146177B (en) Pyrazole compounds as crth2 antagonists
PE20110642A1 (es) Formulaciones antifungicas topicas a base de terbinafina y compuestos similares a terbinafina y metodos de uso
CA2929865C (en) Sprayable topical carrier and composition comprising phosphatidylcholine
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
IN2014DN01619A (pt)
BR112013006362A2 (pt) uso de compostos profármacos de éster de [3-(1-(1h-imidazol-4-il)etil)-2-metilfenil] metanol para reduzir a pressão intraocular, composição farmacêutica e artigo de fabricação
NZ627171A (en) Transmucosal administration system for a pharmaceutical drug
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
BR112012029697A2 (pt) polissacarídeo da semente de tamarindo para uso no tratamento de doenças inflamatórias
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
BR112014001829A2 (pt) composições tópicas antioxidantes
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
WO2011162560A3 (ko) 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
AR086252A1 (es) Formulacion topica que comprende dipropionato de beclometasona como ingrediente activo
TW201129660A (en) Dermal absorption agent comprising felbinac
WO2012169827A3 (ko) 속눈썹 성장용 조성물
MX352595B (es) Composicion farmaceutica que comprende (1r,4r)-6´-fluoro-n,n-dimet il-4-fenil-4´,9´-dihidro-3'h-espiro[ciclohexano-1,1´pirano-[3,4,b ]indol]-4-amina y un componente de acido salicilico.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/06/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.